RK-023 evaluation of safety, tolerability & PK of 5-day application

• Research type

  Research Study

• Full title

  Phase 1 RK-023 Study: Evaluating the safety, tolerability and pharmacokinetics with 5-days of repeated application.

• IRAS ID

  69335

• Contact name

  Ronnie Beboso

• Contact email

  ronnie.beboso@chiltern.com

• Sponsor organisation

  R-Tech Ueno Limited

• Eudract number

  2011-000196-14

• Research summary

  Research Summary not published at request of researcher

• REC name

  Scotland A REC

• REC reference

  11/IE/0006

• Date of REC Opinion

  7 Jun 2011

• REC opinion

  Further Information Favourable Opinion